Skip to main content
. 2016 Oct 4;214(Suppl 3):S326–S332. doi: 10.1093/infdis/jiw250

Figure 3.

Figure 3.

Survival, clinical scores, and viremia levels among adenovirus type 5 (Ad5) Ebola virus (EBOV) variant Makona glycoprotein (MakGP)–vaccinated nonhuman primates after challenge with EBOV-C07. Survival (A), clinical scores (B), and viremia levels measured by quantitative reverse transcription–polymerase chain reaction (C) and by live virus titration (D). Abbreviations: GEQ, genome equivalents; TCID50, 50% tissue culture infective dose.